Nanjing Well Pharmaceutical Co Ltd (603351.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100003JD4
Nanjing Well Pharmaceutical Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.30 bn CNY | 1.34 bn CNY |
| Gross profit | 358.26 m CNY | 380.00 m CNY |
| Operating income | 172.35 m CNY | 187.53 m CNY |
| EBIT | 186.43 m CNY | 183.33 m CNY |
| Net income | 146.42 m CNY | 150.97 m CNY |
| Diluted EPS – continuing operations | 1.08 CNY | 1.11 CNY |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Nanjing Well Pharmaceutical Co Ltd
Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China and internationally. The company offers excipients for injection, oral, and topical applications; and active pharmaceutical ingredients (API), such as polidocanol and polyethylene glycol 3350 API/polyethylene glycol 4000 API. It also provides biomaterial products; water-ethylene glycol fire resistant hydraulic fluid, biodegradable hydraulic fluid base oil, full synthetic hydraulic fluid and compressor base oil, vehicle air conditioning compressor base oil, ester base oil for refrigeration compressor, gear oil, gear oil synthetic ester additive, base oil, synthetic esters, additive of metal working oil, lubricity additive for metal working fluid, base oil and additives for rolling oil, ester type emulsifier, special emulsifier for knitting machine oil, self-emulsifying ester, polyether products, ether type nonionic surfactant, auxiliaries of POY and FDY, as well as base oil for grease, automotive engines, and transmissions. In addition, the company offers Yangzhou well and research institute products; and a-linolenic acid, methyl and ethyl linolenate, linoleic acid, methyl linoleate, ethyl linoleate, EPA ethyl ester, oleic acid, methyl and ethyl oleate, arachidonic acid, methyl arachidonate, arachidonic acid ethyl ester, DHA oil, nervonic acid, eicosenoic acid, palmitoleic acid, palmitoleic acid methyl ester, "-linolenic acid, and "-linolenic acid methyl and ethyl esters. The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020. Nanjing Well Pharmaceutical Group Co.,Ltd. was founded in 2000 and is based in Nanjing, China.
More stocks
- Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212.SS)
- Vatti Corp Ltd (002035.SZ)
- Bank7 Corp. (BSVN)
- SHENANDOAH TELECOMMUNICATIONS CO/VA/ (SHEN)
- Wuhu Sanlian Forging Co Ltd (001282.SZ)
- Yoantion Industrial Inc.Ltd. (301053.SZ)
- Shenzhen Refond Optoelectronics Co Ltd (300241.SZ)
- Azzas 2154 S.A. (AZZA3.SA)
- COLONY BANKCORP INC (CBAN)
- Tatton Asset Management PLC (TAM.L)
- PCL Technologies Inc (4977.TW)
- Zhejiang Xiantong Rubber&Plastic Co Ltd (603239.SS)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.